Skip to main content
. 2020 Oct 14;2020(10):CD012796. doi: 10.1002/14651858.CD012796.pub2

1. Individual targeted agents to be searched.

Axitinib
Bevacizumab
Dovitinib
Erlotinib
Everolimus
Lapatinib
Pazopanib
Sorafenib
Sunitinib
Temsirolimus
Tivozanib
Other agents identified during search